Page 46 - Nasdaq First News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Investegate announcements from Arcoma AB, Arcoma receives first order on the new product, OMNERA 500A

2021-06-10 PRESSRELEASE Arcoma receives first order on the new product, OMNERA 500A Arcoma AB has received the first order on the new product OMNERA 500A. The OMNERA 500A is a new X-ray

Onxeo S.A. Onxeo” or “ the Company”), a clinical-stage biotechnology company specializing in the development of innovative drugs targeting tumor DNA Damage response (DDR), in particular against rare or resistant cancers, today announced that it has received from the U.S. Patent and Trademark Office (USPTO), a Notice Allowance for a patent which enhances in the United States the protection of AsiDNA™, its first-in-class inhibitor of tumor DNA repair, in combination with any PARP inhibitor (PARPi). This patent protects both the combination of AsiDNA™ with a PARPi and its use for the ...

Investegate announcements from Faron Pharma. Oy, Bexmarilimab results published in CCR

Nasdaq Nordic: Nasdaq Copenhagen welcomes Donkey Republic A/S to Nasdaq First North Growth Market Copenhagen May 25, 2021 - Nasdaq (Nasdaq: NDAQ) announces that trading in the Donkey Republic share (short name: DONKEY) starts today on Nasdaq First North Growth Market Denmark. Donkey Republic belongs to the Consumer Products & Services technology sector and is the 10th company which will be admitted to trading on Nasdaq Copenhagen in 2021 and is the 55th company on the Nasdaq Nordic Market*. Donkey Republic is a leading provider of end-to-end bike-sharing solutions. The Company is expanding a...